alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from 
Riverside Park Associates Limited Partnership 1998 Second Quarter 10-QSB
and is qualified in its entirety by reference to such 10-QSB filing.
</LEGEND>
<CIK> 0000813812
<NAME> RIVERSIDE PARK ASSOCIATES LIMITED PARTNERSHIP
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                    6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998   
<CASH>                                           2,602
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                          73,646
<DEPRECIATION>                                  33,024   
<TOTAL-ASSETS>                                  45,372   
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                         45,834     
<PREFERRED-MANDATORY>                                0     
<PREFERRED>                                          0  
<COMMON>                                             0
<OTHER-SE>                                     (1,961)    
<TOTAL-LIABILITY-AND-EQUITY>                    45,372    
<SALES>                                              0
<TOTAL-REVENUES>                                 5,491    
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 6,036    
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,120    
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (545)     
<EPS-PRIMARY>                                    (935)<F2>
<EPS-DILUTED>                                        0
<FN>
<F1>Registrant has an unclassified balance sheet.
<F2>Multiplier is 1.
</FN>
        


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                              62
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                    62
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                      62
<CURRENT-LIABILITIES>                        1,323,962
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        45,996
<OTHER-SE>                                 (2,611,897)
<TOTAL-LIABILITY-AND-EQUITY>                        62
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                28,865
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,690
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                (42,555)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (42,555)
<EPS-BASIC>                                     (0.00)
<EPS-DILUTED>                                   (0.00)


</TABLE>
Editorial Note on Part 25
Editorial Note: Nomenclature changes to part 25 appear at 88 FR 45065, July 14, 2023.

§ 25.52 Environmental impact statements. ( a ) If FDA determines that an EIS is necessary for an action involving investigations, approvals, or market authorizations for drugs, animal drugs, biologic products, devices, or tobacco products, an EIS will be prepared but will become available only at the time of the approval or market authorization of the product. The EIS will in all other respects conform to the requirements for EIS's as specified in 40 CFR part 1502 and 1506.6(f).
( b ) Comments on the EIS may be submitted after the approval or market authorization of the drug, animal drug, biologic product, device, or tobacco product. Those comments can form the basis for the Agency to consider beginning an action to withdraw the approval or market authorization of applications for a drug, animal drug, biologic product, or tobacco product, or to withdraw premarket notifications or premarket approval applications for devices.
( c ) In those cases where the existence of applications and premarket notifications for drugs, animal drugs, biologic products, devices, or tobacco products has already been disclosed before the Agency approves the action, the Agency will ensure appropriate public involvement consistent with 40 CFR 1506.6 and part 1503 in preparing and implementing the NEPA procedures related to preparing EISs while following its own disclosure requirements including those listed in part 20 and §§ 312.130(b), 314.430(d), 514.11(d), 514.12(b), 601.51(d), 807.95(e), 812.38(b), and 814.9(d) of this chapter.
( d ) Draft and final EIS's, comments, and responses will be included in the administrative record and will be available from the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
[62 FR 40592, July 29, 1997, as amended at 68 FR 24879, May 9, 2003; 80 FR 57535, Sept. 24, 2015]
.^ ?Z,q=ft-oi

Mr. Mario Perez

TDCJ-CID #1534249

Connally Unit

899 Fm. 632 RE

Kenedy,Tx. 78119 COURT OF

March 21,2015

Texas Court of Criminal Appeals

Court Clerk-Mr-Abel Acosta Alflipl

P.O. Box 12308

Capitol Station

Austin,Tx.78711

Re: Ex parte Mario Perez, Trial Court Nos. 2006-CR^5055B-Wj., 2006-CR-5056B-W1,'

2006-CR-50"57B~Wi "(399th District Court Bexar County,Texas)

Dear Court Clerk:

Greetings,! reeieved your notation,verifying that the Court reeieved my moat recent

missive.All in regards;to the Writ of Habeas Corpus's in above cause numbers ..The Court

of Criminal Appeals response stated,(on March ]0^201.5 application for Writ of Mandamus

has been presented to the'Court.)NoWjcould you please inforra me,if the Court has granted

an order towards the application for Writ of Mandamus.Also could you please notify me upon

recieving my ibree. applications for Writ of Habeas Corpus,their supporting documents,

and related -records to your office.

THANK YOU VERY MUCH FOR YOUR TIME AND ASSISTANCE.

Respectfully submitted,

CC: File.

25 2015
```

[Federal Register Volume 78, Number 80 (Thursday, April 25, 2013)]
[Notices]
[Page 24386]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09848]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION

Sunshine Act Meetings

TIME AND DATE: 10:00 a.m., Friday, May 10, 2013.

PLACE: 1155 21st St. NW., Washington, DC, 9th Floor Commission 
Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance and Enforcement Matters. In the 
event that the times or dates of this or any future meetings change, an 
announcement of the change, along with the new time and place of the 
meeting will be posted on the Commission's Web site at http://www.cftc.gov.

CONTACT PERSON FOR MORE INFORMATION: Melissa D. Jurgens, 202-418-5516.

Natise Stowe,
Executive Assistant.
[FR Doc. 2013-09848 Filed 4-23-13; 11:15 am]
BILLING CODE 6351-01-P
```
### Water resources of the New Jersey part of the Ramapo River basin

By: John VecchioliE.G. Miller

                            https://doi.org/10.3133/wsp1974

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plates:                               - **Plate 1**                            (pdf)
  - **Plate 2**                            (pdf)
  - **Plate 3**                            (pdf)
  - **Plate 4**                            (pdf) 
- Superseded Publications:
                                        Water resources of the New Jersey part of the Ramapo River basin(1970)                                    

- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
Order entered May 3, 2013

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-12-00776-CV

IN THE INTEREST OF W.R.B. AND B.K.B., CHILDREN

On Appeal from the 256th Judicial District Court

Dallas County, Texas

Trial Court Cause No. 96-12454-Z

ORDER

We GRANT appellee’s May 1, 2013 unopposed motion for leave to file a sur-reply brief. 

We ORDER the sur-reply brief tendered to this Court by appellee on May 1, 2013 filed as of the 

date of this order.

/s/ CAROLYN WRIGHT

CHIEF JUSTICE
[Federal Register Volume 75, Number 38 (Friday, February 26, 2010)]
[Notices]
[Page 8979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3926]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, IDD P30 RFA.
    Date: March 21-23, 2010.
    Time: 7 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Norman Chang, PhD, Scientific Review Officer, 
Division of Scientific Review, Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, NIH, 6100 Executive 
Blvd., Room 5B01, Bethesda, MD 20892. (301) 496-1485. 
<a href="/cdn-cgi/l/email-protection#f2919a939c959cb29f939b9edc9c9b9adc959d84"><span class="__cf_email__" data-cfemail="d8bbb0b9b6bfb698b5b9b1b4f6b6b1b0f6bfb7ae">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: February 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3926 Filed 2-25-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 556.720 Tetracycline. ( a ) *Acceptable daily intake (ADI).* The ADI for total tetracycline residues (chlortetracycline, oxytetracycline, and tetracycline) is 25 μg/kg of body weight per day.
( b ) *Tolerances.* The tolerances for the sum of tetracycline residues are: ( 1 ) *Cattle and sheep.* ( i ) Kidney and fat: 12 ppm.
( ii ) Liver: 6 ppm.
( iii ) Muscle: 2 ppm.
( 2 ) *Chickens and turkeys.* ( i ) Kidney and fat: 12 ppm.
( ii ) Liver: 6 ppm.
( iii ) Muscle: 2 ppm.
( 3 ) *Swine.* ( i ) Kidney and fat: 12 ppm.
( ii ) Liver: 6 ppm.
( iii ) Muscle: 2 ppm.
( c ) *Related conditions of use.* See §§ 520.2345c and 520.2345d of this chapter.
J.

2 SUPREME COURT

OF NEVADA (0) 1947A Tn7,,,INNETIMINIEW-717111111

court because these claims challenged the conditions of confinement. 

### Bowen v. Warden, 100 Nev. 489, 686 P.2d 250 (1984). Accordingly, we

ORDER the judgment of the district court AFFIRMED.
1 - ku.c l iesty Parraguirre cc: Hon. Gary Fairman, District Judge Armond Lewis Attorney General/Carson City Attorney General/Ely White Pine County Clerk
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Small Research Grants Review.                    

*Date:*                         February 4, 2010.                    

*Time:*                         10 a.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Michael L. Bloom, PhD, MBA, Scientific Review Officer, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 Democracy Blvd; Room 820, MSC 4872, Bethesda, MD 20892-4872, 301-594-4953,                         *Michael_Bloom@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)

Dated: January 6, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-421 Filed 1-12-10; 8:45 am]

BILLING CODE 4140-01-P
# L_2019068DE.01001602.xml

| 8.3.2019 | DE | Amtsblatt der Europäischen Union | L 68/16 |
| --- | --- | --- | --- |

8.3.2019

DE

Amtsblatt der Europäischen Union

L 68/16

---

Berichtigung der Durchführungsverordnung (EU) 2018/1584 der Kommission vom 22. Oktober 2018 zur Änderung der Verordnung (EG) Nr. 889/2008 mit Durchführungsvorschriften zur Verordnung (EG) Nr. 834/2007 des Rates über die ökologische/biologische Produktion und die Kennzeichnung von ökologischen/biologischen Erzeugnissen hinsichtlich der ökologischen/biologischen Produktion, Kennzeichnung und Kontrolle

(
  Amtsblatt der Europäischen Union L 264 vom 23. Oktober 2018
  )

Auf Seite 5, Anhang 1 zur Änderung des Anhangs I der Verordnung (EG) Nr. 889/2008, Tabelle Zeile 11 Spalte 3 Absatz 1:

Anstatt:

„Tierische Nebenprodukte (einschließlich Nebenprodukte von Wildtieren) der Kategorie 3 und Magen- und Darminhalt der Kategorie 2 (Kategorien 2 und 3 gemäß der Definition in der Verordnung (EG) Nr. 1069/2009 des Europäischen Parlaments und des Rates (1) dürfen nicht aus der landwirtschaftlichen Erzeugung stammen.“

muss es heißen:

„Tierische Nebenprodukte (einschließlich Nebenprodukte von Wildtieren) der Kategorie 3 und Magen- und Darminhalt der Kategorie 2 (Kategorien 2 und 3 gemäß der Definition in der Verordnung (EG) Nr. 1069/2009 des Europäischen Parlaments und des Rates (1) dürfen nicht aus der industriellen Tierhaltung stammen.“

---
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane l una ni m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T R ON AL D P . GR E E N, P e titio n e r- A p p e llan t, v. J . E . T H O M A S , W ar de n, R es po nd ent- A pp el l ee . N o. 12- 35013 D . C . N o . 3 : 1 1 -cv -0 1 0 0 9 -JE ME MOR AN DU M *

A pp ea l fr om the U ni t ed S t at es D i stri ctC ou rt

f orthe D i s tr i c tof

O r e gon M i c ha e l W . M os m an, D i s tr i c tJudge , P r e s i di ng S ubm i tt e d O c t obe r9, 2012 ** B efo re: R A W L IN S O N , M U R G U IA , an dW A T F O R D , C i rcu i tJu d g es. F ed er al p riso n erR o n aldP . G re en ap p ea ls p ro se fr o m th e d istrict co u rt’s j udgm e ntdi s m i s s i ng hi s 28 U . S . C . § 2241 habe a s pe t i t i on. W e have j ur i s di c t i on u n d e r2 8 U . S. C. § 1 2 9 1 , a n dw e a f f i rm. 

# FI LED OC T 16 2012 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS12- 35013 2 G re en cont ends thathe i s a ctual l y i nn ocentof bei ng a c ar ee r off ender und er U . S . S . G . § 4B 1. 1 and the r e f or e he s houl d be a l l ow e d t o pr oc e e d w i th hi s s e c t i on 2 2 4 1 p e titio n u n d e rth e “e s c ap e h a tc h ” o f 2 8 U .S .C . § 2 2 5 5 ( e ) . T h is c o n te n tio n is f o r e c lo s e d . See M

arre ro v. Iv es , 682 F . 3d 1190, 1195 ( 9th C i r . 2012) ( “ [ T ] he pu re l y l egalar gu m entthata pet i t i on erw as w rong l y c l as si fi ed as a c ar ee r off ender un der the S ent enci ng G ui del i nes i s notcogn i zabl e a s acl ai m of ac tual i nn ocence u n d e rth e e s c ap e h a tc h .” ) . T h e d is tr ic t c o u rt c o rr e c tlyd is m is s e dh is p e titio n . See i d. W e c ons true G r e e n’ s a ddi t i ona l a r gum e nt s a s am ot i on t o e xpa nd the c e rtif ic a te o f ap p e a lab ility . S o c o n s tru e d , th e m o tio n is d e n ie d . See 9th C i r . R . 22- 1 ( e ) ; Hi i v ala v . W

ood , 19 5 F . 3d 10 98 , 11 04 -05 (9th C i r. 19 99 ) ( per c uri am ). AF F I RME D.
Exhibit








                                                                                            Exhibit 10.1
Regulus Therapeutics Inc.


Joseph P. Hagan Yearly Discretionary Base Salary Increase


The Board of Directors (the “Board”) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Mr. Hagan’s annual base salary to $427,450, effective January 1, 2017.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7568 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7568

     To amend the Robert T. Stafford Disaster Relief and Emergency 
   Assistance Act to establish a deadline for applying for disaster 
                        unemployment assistance.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 6, 2024

  Mr. Neguse introduced the following bill; which was referred to the 
             Committee on Transportation and Infrastructure

_______________________________________________________________________

                                 A BILL

 
     To amend the Robert T. Stafford Disaster Relief and Emergency 
   Assistance Act to establish a deadline for applying for disaster 
                        unemployment assistance.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Disaster Assistance Deadlines 
Alignment Act''.

SEC. 2. DISASTER UNEMPLOYMENT ASSISTANCE APPLICATION DEADLINE.

    Section 410 of the Robert T. Stafford Disaster Relief and Emergency 
Assistance Act (42 U.S.C. 5177) is amended by adding at the end the 
following:
    ``(c) Application Deadline.--
            ``(1) In general.--With respect to a major disaster for 
        which assistance is provided under this section and section 
        408, the application deadline for an individual seeking 
        assistance under this section shall match the application 
        deadline for individuals and households seeking assistance 
        under section 408.
            ``(2) Extension.--The President may accept an application 
        from an individual described in paragraph (1) that is submitted 
        after the deadline described in paragraph (1) if--
                    ``(A) the individual has good cause for the late 
                submission; and
                    ``(B) the individual submits the application before 
                the date on which the period during which assistance is 
                provided under this section for the applicable major 
                disaster expires.''.

SEC. 3. APPLICABILITY.

    The amendment made by section 2 shall apply only with respect to 
amounts appropriated on or after the date of enactment of this Act.
                                 <all>
```